跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OLIPLAT POWDER FOR SOLUTION FOR INJECTION 50 MG/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
OLIPLAT POWDER FOR SOLUTION FOR INJECTION 50 MG/VIAL
Approved
THERAPEUTIC
OLIPLAT POWDER FOR SOLUTION FOR INJECTION 50 MG/VIAL
MYLAN LABORATORIES LIMITED [OTL] (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Oct 2, 2012
Approval ID
b31af9f183a73266
Company
MYLAN LABORATORIES LIMITED [OTL] (INDIA)
Type
Therapeutic
Approval Details
Approval Id
b31af9f183a73266
Drug Name
OLIPLAT POWDER FOR SOLUTION FOR INJECTION 50 MG/VIAL
Product Name
OLIPLAT POWDER FOR SOLUTION FOR INJECTION 50 MG/VIAL
Approval Number
SIN14241P
Approval Date
2012-10-02
Registrant
VIATRIS PHARMACEUTICALS PTE. LTD.
Licence Holder
VIATRIS PHARMACEUTICALS PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
L01XA03
Atc Item Name
oxaliplatin
Pharma Manufacturer Name
mylan pharmaceuticals pte. ltd.
Active Ingredients
Oxaliplatin
50.00 mg
OXALIPLATIN
50 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 2, 2012
Approval ID
b31af9f183a73266
Type
Therapeutic
Back to HSA Approvals
